The 2026 conference will feature a new record! Close to 50 presenting companies, primarily from Colorado, will represent the depth of innovation across the Rocky Mountain West. These companies have completed a rigorous selection process and are participating in a comprehensive pitch training process to ensure their investor readiness. They are advancing clinical pipelines, building scalable platforms, and creating value across biotech, pharma, medical device, diagnostics, digital health, animal health, and ag bio.

The conference will be held at the Grand Hyatt Vail, one of Colorado’s premier mountain resorts. Set during peak fall color season, the location offers productive business engagement and access to unmatched golf, hiking, mountain biking, and outdoor experiences. Attendees are encouraged to extend their stay and continue conversations in a setting designed for both focus and inspiration.

Seven-time Olympic medalist, entrepreneur, cancer survivor, and women's health advocate Shannon Miller joins the 2026 Rocky Mountain Life Sciences Investor & Partnering Conference as keynote speaker for the Championing Women's Health Breakfast. New speakers from Janus Henderson Investors, J.P. Morgan, and Terumo Blood and Cell Technologies join previously announced leaders from Nasdaq and CU Boulder.